| Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy R Binato, T de Souza Fernandez, C Lazzarotto‐Silva, B Du Rocher, ... Cell proliferation 46 (1), 10-22, 2013 | 143 | 2013 |
| Wnt/β-catenin pathway regulates ABCB1 transcription in chronic myeloid leukemia S Corrêa, R Binato, B Du Rocher, MTL Castelo-Branco, L Pizzatti, ... BMC cancer 12, 1-11, 2012 | 123 | 2012 |
| Altered protein profile in chronic myeloid leukemia chronic phase identified by a comparative proteomic study L Pizzatti, LA Sá, JM de Souza, PM Bisch, E Abdelhay Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1764 (5), 929-942, 2006 | 66 | 2006 |
| Putative circulating markers of the early and advanced stages of breast cancer identified by high-resolution label-free proteomics C Panis, L Pizzatti, AC Herrera, R Cecchini, E Abdelhay Cancer letters 330 (1), 57-66, 2013 | 63 | 2013 |
| Label‐free MSE proteomic analysis of chronic myeloid leukemia bone marrow plasma: disclosing new insights from therapy resistance L Pizzatti, C Panis, G Lemos, M Rocha, R Cecchini, GHMF Souza, ... Proteomics 12 (17), 2618-2631, 2012 | 47 | 2012 |
| SUZ12 is a candidate target of the non‐canonical WNT pathway in the progression of chronic myeloid leukemia L Pizzatti, R Binato, J Cofre, BE Gomes, J Dobbin, ME Haussmann, ... Genes, Chromosomes and Cancer 49 (2), 107-118, 2010 | 47 | 2010 |
| Oxidative stress, redox signaling and cancer chemoresistance: putting together the pieces of the puzzle V Jacob Victorino, L Pizzatti, P Michelletti, C Panis Current medicinal chemistry 21 (28), 3211-3226, 2014 | 43 | 2014 |
| SMAD 8 binding to mice Msx1 basal promoter is required for transcriptional activation R Binato, CE Alvarez Martinez, L Pizzatti, B Robert, E Abdelhay Biochemical Journal 393 (1), 141-150, 2006 | 42 | 2006 |
| Kaurenoic Acid Possesses Leishmanicidal Activity by Triggering a NLRP12/IL‐1β/cNOS/NO Pathway MM Miranda, C Panis, SS da Silva, JA Macri, NY Kawakami, ... Mediators of inflammation 2015 (1), 392918, 2015 | 40 | 2015 |
| Doping control analysis at the Rio 2016 Olympic and Paralympic Games HMG Pereira, VF Sardela, MC Padilha, L Mirotti, A Casilli, FA de Oliveira, ... Drug testing and analysis 9 (11-12), 1658-1672, 2017 | 35 | 2017 |
| Knock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of chronic myeloid leukemia J Cofre, JRL Menezes, L Pizzatti, E Abdelhay Cancer cell international 12, 1-14, 2012 | 34 | 2012 |
| Identifying potential markers in breast cancer subtypes using plasma label-free proteomics S Corrêa, C Panis, R Binato, AC Herrera, L Pizzatti, E Abdelhay Journal of proteomics 151, 33-42, 2017 | 32 | 2017 |
| Clinical proteomics in cancer: Where we are C Panis, L Pizzatti, GF Souza, E Abdelhay Cancer Letters 382 (2), 231-239, 2016 | 32 | 2016 |
| Label-free proteomic analysis of breast cancer molecular subtypes C Panis, L Pizzatti, AC Herrera, S Corrêa, R Binato, E Abdelhay Journal of proteome research 13 (11), 4752-4772, 2014 | 32 | 2014 |
| Proteomic workflows for high-quality quantitative proteome and post-translational modification analysis of clinically relevant samples from formalin-fixed paraffin-embedded … M Kuras, N Woldmar, Y Kim, M Hefner, J Malm, J Moldvay, B Dome, ... Journal of Proteome Research 20 (1), 1027-1039, 2020 | 29 | 2020 |
| Gene doping and genomic science in sports: where are we? S López, J Meirelles, V Rayol, G Poralla, N Woldmar, B Fadel, ... Bioanalysis 12 (11), 801-811, 2020 | 27 | 2020 |
| Label‐Free Proteomics Revealed Oxidative Stress and Inflammation as Factors That Enhance Chemoresistance in Luminal Breast Cancer BRB Pires, C Panis, VD Alves, ACSA Herrera, R Binato, L Pizzatti, ... Oxidative Medicine and Cellular Longevity 2019 (1), 5357649, 2019 | 24 | 2019 |
| Discovering the infectome of human endothelial cells challenged with Aspergillus fumigatus applying a mass spectrometry label-free approach N Curty, PH Kubitschek-Barreira, GW Neves, D Gomes, L Pizzatti, ... Journal of Proteomics 97, 126-140, 2014 | 24 | 2014 |
| A comparative proteomic study identified LRPPRC and MCM7 as putative actors in imatinib mesylate cross-resistance in Lucena cell line S Corrêa, L Pizzatti, B Du Rocher, A Mencalha, D Pinto, E Abdelhay Proteome Science 10, 1-18, 2012 | 24 | 2012 |
| The human melanoma proteome atlas—Complementing the melanoma transcriptome LH Betancourt, J Gil, A Sanchez, V Doma, M Kuras, JR Murillo, ... Clinical and Translational Medicine 11 (7), e451, 2021 | 22 | 2021 |
